Abstract
Motivation: Computational techniques for drug-disease prediction are essential in enhancing drug discovery and repositioning. While many methods utilize multimodal networks from various biological databases, few integrate comprehensive multi-omics data, including transcriptomes, proteomes, and metabolomes. We introduce STRGNN, a novel graph deep learning approach that predicts drug-disease relationships using extensive multimodal networks comprising proteins, RNAs, metabolites, and compounds. We have constructed a detailed dataset incorporating multi-omics data and developed a learning algorithm with topological regularization. This algorithm selectively leverages informative modalities while filtering out redundancies. Results: STRGNN demonstrates superior accuracy compared to existing methods and has identified several novel drug effects, corroborating existing literature. STRGNN emerges as a powerful tool for drug prediction and discovery. The source code for STRGNN, along with the dataset for performance evaluation, is available at https://github.com/yuto-ohnuki/STRGNN.git.
Author supplied keywords
Cite
CITATION STYLE
Ohnuki, Y., Akiyama, M., & Sakakibara, Y. (2024). Deep learning of multimodal networks with topological regularization for drug repositioning. Journal of Cheminformatics, 16(1). https://doi.org/10.1186/s13321-024-00897-y
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.